Aceragen OverviewAceragen Research & Development
Research & Development expenses for ACGN.
Quarterly R&D Expenses
N/A
As of Mar 31, 2023
Annual R&D Expenses (TTM)
$10.40M
↓ 7.83% YoY
Trailing 12 months ending Mar 31, 2023
Aceragen OverviewResearch & Development expenses for ACGN.
As of Mar 31, 2023
Trailing 12 months ending Mar 31, 2023